New application method of zanamivir with a straw

Pediatrics International

Volumn 45, Issue 3, 2003, Pages 366-367

  Imuta, Fusae ^a   Toyoda, Michiko ^b   Toyoda, Tetsuya ^c,d  

^a Imuta Pediatric Clinic   (Japan)

^b Mishima Hospital   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE   (Japan)

Author keywords

Influenza virus; Straw; Zanamivir

Indexed keywords

ZANAMIVIR;

AGE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; INFLUENZA; INFLUENZA VIRUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; STRAW; TECHNIQUE; URTICARIA;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; GUANIDINES; HUMANS; INFANT; INFLUENZA, HUMAN; PYRANS; SIALIC ACIDS; ZANAMIVIR;

EID: 0043165028     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01724.x     Document Type: Article

References (9)

1. Glezen WP. Consideration of the risk of influenza in children and indications for prophylaxis. Rev. Infect. Dis. 1980; 2: 408-20.
2. Hayden FG, Osterhaus AD, Treanor JJ et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N. Engl. J. Med. 1997; 337: 874-80.
3. Sugaya N. Influenza vaccine, anti-influenza drugs, and rapid diagnosis in Japan. J. Infect. Chemother. 2000; 6: 77-80.
4. The MIST Study Group. Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998; 352: 1877-81.
5. Monto AS, Fleming DM, Henry D et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J. Infect. Dis. 1999; 180: 254-61.
6. Monto AS, Robinson DP, Herlocher ML, Hinson JM, Elliot MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999; 282: 31-5.
7. Glesen WP, Cherry JD. Influenza viruses. In: Feign RD, Cherry JD, (eds). Textbook of Pediatric Infectious Diseases, 3rd edn. WB Saunders, Philadelphia, 1992; 1688-704.
8. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2002; 51: 1-31.
9. Hedrick JA, Barzilai A, Behre U et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr. Infect. Dis. J. 2000; 19: 410-17.